Soligenix Inc. (NASDAQ: SNGX) Receives Strong Vote of Confidence from Zacks Report Despite Muted Market Response to Clinical Milestone
The report maintains $25 per share valuation for Soligenix, based on a probability-adjusted discounted cash flow model that considers potential…